Lv62
2430 积分 2022-05-19 加入
Assessing the clinical progress of the bispecific nanobody sonelokimab
17天前
已完结
A Novel Designed Anti–PD-L1/OX40 Bispecific Antibody Augments Both Peripheral and Tumor-Associated Immune Responses for Boosting Antitumor Immunity
3个月前
已完结
Single-Domain Antibodies
3个月前
已完结
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
5个月前
已完结
A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement
7个月前
已完结
Overcoming Instability of Antibody‐Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies
7个月前
已完结
Natural killer cell therapies
8个月前
已完结
Anti-tumor immunity is boosted by loss of TGFβ-driven tissue residency
8个月前
已关闭
皖公网安备34019202002308
